UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 24, 2006
Targeted Genetics Corporation
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Washington
|
|
0-23930
|
|
91-1549568 |
| |
(State or other jurisdiction
of incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.) |
| |
|
|
| 1100 Olive Way, Suite 100, Seattle, Washington
|
|
98101 |
| |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code (206) 623-7612
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On January 24, 2006, Targeted Genetics Corporation announced the restructuring of its
operations to reduce expenses and realign resources to advance its lead product candidate, tgAAC94,
through clinical trials as quickly as possible. In connection with this restructuring, Targeted
Genetics reduced its workforce by approximately 27% or 26 employees, primarily in early-stage
research and development groups and in general and administrative functions. A press release
announcing this restructuring is attached as Exhibit 99.1 to this current report and is
incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
| |
99.1 |
|
Press Release of Targeted Genetics Corporation dated January 24, 2006 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
|
|
|
|
| |
Targeted Genetics Corporation
|
|
| |
By: |
/s/ H. Stewart Parker
|
|
| |
|
H. Stewart Parker |
|
| |
|
President and Chief Executive Officer |
|
| |
Dated: January 25, 2006
3